Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Psoriasis Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Psoriasis Drug market. Detailed analysis of key players, along with key growth strategies adopted by Psoriasis Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bristol-Myers Squibb
Merz Pharma
Valeant
Bayer
Galderma
LEO Pharma
Johnson & Johnson
AbbVie
GlaxoSmithKline
Novartis
Pfizer
By Type:
External Use
Oral
Injection
By End-User:
Injection
Injection
Injection
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Psoriasis Drug Market
-
1.3 Market Segment by Type
1.3.1 Japan Psoriasis Drug Market Size and Growth Rate of External Use from 2014 to 2026
1.3.2 Japan Psoriasis Drug Market Size and Growth Rate of Oral from 2014 to 2026
1.3.3 Japan Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026
1.4.2 Japan Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026
1.4.3 Japan Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Psoriasis Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Psoriasis Drug by Major Types
3.4.1 Market Size and Growth Rate of External Use
3.4.2 Market Size and Growth Rate of Oral
3.4.3 Market Size and Growth Rate of Injection
4 Segmentation of Psoriasis Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Psoriasis Drug by Major End-Users
4.4.1 Market Size and Growth Rate of Psoriasis Drug in Injection
4.4.2 Market Size and Growth Rate of Psoriasis Drug in Injection
4.4.3 Market Size and Growth Rate of Psoriasis Drug in Injection
5 Market Analysis by Regions
-
5.1 Japan Psoriasis Drug Production Analysis by Regions
-
5.2 Japan Psoriasis Drug Consumption Analysis by Regions
6 Hokkaido Psoriasis Drug Landscape Analysis
-
6.1 Hokkaido Psoriasis Drug Landscape Analysis by Major Types
-
6.2 Hokkaido Psoriasis Drug Landscape Analysis by Major End-Users
7 Tohoku Psoriasis Drug Landscape Analysis
-
7.1 Tohoku Psoriasis Drug Landscape Analysis by Major Types
-
7.2 Tohoku Psoriasis Drug Landscape Analysis by Major End-Users
8 Kanto Psoriasis Drug Landscape Analysis
-
8.1 Kanto Psoriasis Drug Landscape Analysis by Major Types
-
8.2 Kanto Psoriasis Drug Landscape Analysis by Major End-Users
9 Chubu Psoriasis Drug Landscape Analysis
-
9.1 Chubu Psoriasis Drug Landscape Analysis by Major Types
-
9.2 Chubu Psoriasis Drug Landscape Analysis by Major End-Users
10 Kinki Psoriasis Drug Landscape Analysis
-
10.1 Kinki Psoriasis Drug Landscape Analysis by Major Types
-
10.2 Kinki Psoriasis Drug Landscape Analysis by Major End-Users
11 Chugoku Psoriasis Drug Landscape Analysis
-
11.1 Chugoku Psoriasis Drug Landscape Analysis by Major Types
-
11.2 Chugoku Psoriasis Drug Landscape Analysis by Major End-Users
12 Shikoku Psoriasis Drug Landscape Analysis
-
12.1 Shikoku Psoriasis Drug Landscape Analysis by Major Types
-
12.2 Shikoku Psoriasis Drug Landscape Analysis by Major End-Users
13 Kyushu Psoriasis Drug Landscape Analysis
-
13.1 Kyushu Psoriasis Drug Landscape Analysis by Major Types
-
13.2 Kyushu Psoriasis Drug Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Bristol-Myers Squibb
14.1.1 Bristol-Myers Squibb Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Merz Pharma
14.2.1 Merz Pharma Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Valeant
14.3.1 Valeant Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Bayer
14.4.1 Bayer Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Galderma
14.5.1 Galderma Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 LEO Pharma
14.6.1 LEO Pharma Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Johnson & Johnson
14.7.1 Johnson & Johnson Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 AbbVie
14.8.1 AbbVie Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 GlaxoSmithKline
14.9.1 GlaxoSmithKline Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Novartis
14.10.1 Novartis Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Pfizer
14.11.1 Pfizer Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
The List of Tables and Figures (Totals 85 Figures and 141 Tables)
Figure Japan Psoriasis Drug Market Size and Growth Rate of External Use from 2014 to 2026
Figure Japan Psoriasis Drug Market Size and Growth Rate of Oral from 2014 to 2026
Figure Japan Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026
Figure Japan Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026
Figure Japan Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Psoriasis Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Psoriasis Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Psoriasis Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Psoriasis Drug by Different Types from 2014 to 2026
-
Table Consumption Share of Psoriasis Drug by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of External Use
Figure Market Size and Growth Rate of Oral
Figure Market Size and Growth Rate of Injection
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Psoriasis Drug by Different End-Users from 2014 to 2026
-
Table Consumption Share of Psoriasis Drug by Different End-Users from 2014 to 2026
Figure Japan Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026
Figure Japan Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026
Figure Japan Psoriasis Drug Market Size and Growth Rate of Injection from 2014 to 2026
-
Table Japan Psoriasis Drug Production by Regions
-
Table Japan Psoriasis Drug Production Share by Regions
-
Figure Japan Psoriasis Drug Production Share by Regions in 2014
-
Figure Japan Psoriasis Drug Production Share by Regions in 2018
-
Figure Japan Psoriasis Drug Production Share by Regions in 2026
-
Table Japan Psoriasis Drug Consumption by Regions
-
Table Japan Psoriasis Drug Consumption Share by Regions
-
Figure Japan Psoriasis Drug Consumption Share by Regions in 2014
-
Figure Japan Psoriasis Drug Consumption Share by Regions in 2018
-
Figure Japan Psoriasis Drug Consumption Share by Regions in 2026
-
Table Hokkaido Psoriasis Drug Consumption by Types from 2014 to 2026
-
Table Hokkaido Psoriasis Drug Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Psoriasis Drug Consumption Share by Types in 2014
-
Figure Hokkaido Psoriasis Drug Consumption Share by Types in 2018
-
Figure Hokkaido Psoriasis Drug Consumption Share by Types in 2026
-
Table Hokkaido Psoriasis Drug Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Psoriasis Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Psoriasis Drug Consumption Share by End-Users in 2014
-
Figure Hokkaido Psoriasis Drug Consumption Share by End-Users in 2018
-
Figure Hokkaido Psoriasis Drug Consumption Share by End-Users in 2026
-
Table Tohoku Psoriasis Drug Consumption by Types from 2014 to 2026
-
Table Tohoku Psoriasis Drug Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Psoriasis Drug Consumption Share by Types in 2014
-
Figure Tohoku Psoriasis Drug Consumption Share by Types in 2018
-
Figure Tohoku Psoriasis Drug Consumption Share by Types in 2026
-
Table Tohoku Psoriasis Drug Consumption by End-Users from 2014 to 2026
-
Table Tohoku Psoriasis Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Psoriasis Drug Consumption Share by End-Users in 2014
-
Figure Tohoku Psoriasis Drug Consumption Share by End-Users in 2018
-
Figure Tohoku Psoriasis Drug Consumption Share by End-Users in 2026
-
Table Kanto Psoriasis Drug Consumption by Types from 2014 to 2026
-
Table Kanto Psoriasis Drug Consumption Share by Types from 2014 to 2026
-
Figure Kanto Psoriasis Drug Consumption Share by Types in 2014
-
Figure Kanto Psoriasis Drug Consumption Share by Types in 2018
-
Figure Kanto Psoriasis Drug Consumption Share by Types in 2026
-
Table Kanto Psoriasis Drug Consumption by End-Users from 2014 to 2026
-
Table Kanto Psoriasis Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Psoriasis Drug Consumption Share by End-Users in 2014
-
Figure Kanto Psoriasis Drug Consumption Share by End-Users in 2018
-
Figure Kanto Psoriasis Drug Consumption Share by End-Users in 2026
-
Table Chubu Psoriasis Drug Consumption by Types from 2014 to 2026
-
Table Chubu Psoriasis Drug Consumption Share by Types from 2014 to 2026
-
Figure Chubu Psoriasis Drug Consumption Share by Types in 2014
-
Figure Chubu Psoriasis Drug Consumption Share by Types in 2018
-
Figure Chubu Psoriasis Drug Consumption Share by Types in 2026
-
Table Chubu Psoriasis Drug Consumption by End-Users from 2014 to 2026
-
Table Chubu Psoriasis Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Psoriasis Drug Consumption Share by End-Users in 2014
-
Figure Chubu Psoriasis Drug Consumption Share by End-Users in 2018
-
Figure Chubu Psoriasis Drug Consumption Share by End-Users in 2026
-
Table Kinki Psoriasis Drug Consumption by Types from 2014 to 2026
-
Table Kinki Psoriasis Drug Consumption Share by Types from 2014 to 2026
-
Figure Kinki Psoriasis Drug Consumption Share by Types in 2014
-
Figure Kinki Psoriasis Drug Consumption Share by Types in 2018
-
Figure Kinki Psoriasis Drug Consumption Share by Types in 2026
-
Table Kinki Psoriasis Drug Consumption by End-Users from 2014 to 2026
-
Table Kinki Psoriasis Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Psoriasis Drug Consumption Share by End-Users in 2014
-
Figure Kinki Psoriasis Drug Consumption Share by End-Users in 2018
-
Figure Kinki Psoriasis Drug Consumption Share by End-Users in 2026
-
Table Chugoku Psoriasis Drug Consumption by Types from 2014 to 2026
-
Table Chugoku Psoriasis Drug Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Psoriasis Drug Consumption Share by Types in 2014
-
Figure Chugoku Psoriasis Drug Consumption Share by Types in 2018
-
Figure Chugoku Psoriasis Drug Consumption Share by Types in 2026
-
Table Chugoku Psoriasis Drug Consumption by End-Users from 2014 to 2026
-
Table Chugoku Psoriasis Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Psoriasis Drug Consumption Share by End-Users in 2014
-
Figure Chugoku Psoriasis Drug Consumption Share by End-Users in 2018
-
Figure Chugoku Psoriasis Drug Consumption Share by End-Users in 2026
-
Table Shikoku Psoriasis Drug Consumption by Types from 2014 to 2026
-
Table Shikoku Psoriasis Drug Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Psoriasis Drug Consumption Share by Types in 2014
-
Figure Shikoku Psoriasis Drug Consumption Share by Types in 2018
-
Figure Shikoku Psoriasis Drug Consumption Share by Types in 2026
-
Table Shikoku Psoriasis Drug Consumption by End-Users from 2014 to 2026
-
Table Shikoku Psoriasis Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Psoriasis Drug Consumption Share by End-Users in 2014
-
Figure Shikoku Psoriasis Drug Consumption Share by End-Users in 2018
-
Figure Shikoku Psoriasis Drug Consumption Share by End-Users in 2026
-
Table Kyushu Psoriasis Drug Consumption by Types from 2014 to 2026
-
Table Kyushu Psoriasis Drug Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Psoriasis Drug Consumption Share by Types in 2014
-
Figure Kyushu Psoriasis Drug Consumption Share by Types in 2018
-
Figure Kyushu Psoriasis Drug Consumption Share by Types in 2026
-
Table Kyushu Psoriasis Drug Consumption by End-Users from 2014 to 2026
-
Table Kyushu Psoriasis Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Psoriasis Drug Consumption Share by End-Users in 2014
-
Figure Kyushu Psoriasis Drug Consumption Share by End-Users in 2018
-
Figure Kyushu Psoriasis Drug Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Bristol-Myers Squibb
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
Table Product and Service Introduction of Bristol-Myers Squibb
Table Company Profile and Development Status of Merz Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merz Pharma
Figure Sales and Growth Rate Analysis of Merz Pharma
Figure Revenue and Market Share Analysis of Merz Pharma
Table Product and Service Introduction of Merz Pharma
Table Company Profile and Development Status of Valeant
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant
Figure Sales and Growth Rate Analysis of Valeant
Figure Revenue and Market Share Analysis of Valeant
Table Product and Service Introduction of Valeant
Table Company Profile and Development Status of Bayer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
Figure Sales and Growth Rate Analysis of Bayer
Figure Revenue and Market Share Analysis of Bayer
Table Product and Service Introduction of Bayer
Table Company Profile and Development Status of Galderma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galderma
Figure Sales and Growth Rate Analysis of Galderma
Figure Revenue and Market Share Analysis of Galderma
Table Product and Service Introduction of Galderma
Table Company Profile and Development Status of LEO Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of LEO Pharma
Figure Sales and Growth Rate Analysis of LEO Pharma
Figure Revenue and Market Share Analysis of LEO Pharma
Table Product and Service Introduction of LEO Pharma
Table Company Profile and Development Status of Johnson & Johnson
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
Figure Sales and Growth Rate Analysis of Johnson & Johnson
Figure Revenue and Market Share Analysis of Johnson & Johnson
Table Product and Service Introduction of Johnson & Johnson
Table Company Profile and Development Status of AbbVie
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
Figure Sales and Growth Rate Analysis of AbbVie
Figure Revenue and Market Share Analysis of AbbVie
Table Product and Service Introduction of AbbVie
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of Novartis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
Figure Sales and Growth Rate Analysis of Novartis
Figure Revenue and Market Share Analysis of Novartis
Table Product and Service Introduction of Novartis
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
-
